Organogenesis Holdings Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Canton, MA
ORGO chart
What traders are saying about $ORGO
Latest postsOrganogenesis Holdings Inc. news
- Weekly Recap: Full-year guidance cut and PREPARE trial meets endpoints
TradingView ·
- Organogenesis Holdings Inc. (ORGO) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Organogenesis Holdings Inc (ORGO) Q3 2026 Earnings Call Highligh
GuruFocus ·
- Organogenesis Holdings Inc (ORGO) Q3 2026 Earnings Call Highlights: Market Bottom, Cost Cuts, ...
Yahoo Finance ·
- Organogenesis Earnings Call Signals Recovery Amid Major Setbacks
TipRanks ·
- Organogenesis Holdings Inc. (ORGO) Seasonal returns chart
Yahoo Finance Singapore ·
- Regenerative medicine company shows signs of recovery after policy changes upend industry
The Business Journals ·
- Organogenesis Q3 Adjusted Ebitda USD -22.4 Mi
Moomoo ·
- Organogenesis Holdings Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Organogenesis: 3 Key Takeaways for Long-Term Investors
fool.com ·
- Organogenesis (ORGO) Q3 2026 Earnings Call Transcript
fool.com ·
- Organogenesis Holdings earnings missed by $0.07, revenue fell short of estimates
Investing.com Australia ·
Organogenesis Holdings Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $564.2M | $482.0M | $433.1M | $450.9M |
| Net income | $37.0M | $900,000 | $4.9M | $15.5M |
| Diluted EPS | $0.15 | $-0.01 | $0.04 | $0.12 |
| Total assets (year end) | $598.7M | $497.9M | $460.0M | $449.4M |
| Cash and equivalents (year end) | $93.7M | $135.6M | $103.8M | $102.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Organogenesis Holdings Inc.
- Ticker
- ORGO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Canton, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1661181
- Former names
- Avista Healthcare Public Acquisition Corp.
Frequently asked questions
What exchange is Organogenesis Holdings Inc. listed on?
Organogenesis Holdings Inc. trades on the Nasdaq under the ticker symbol ORGO.
What industry is Organogenesis Holdings Inc. in?
Organogenesis Holdings Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Organogenesis Holdings Inc. headquartered?
Organogenesis Holdings Inc.'s business address on file with the SEC is in Canton, MA.
When does Organogenesis Holdings Inc.'s fiscal year end?
Organogenesis Holdings Inc.'s fiscal year ends on December 31.
How much revenue did Organogenesis Holdings Inc. report?
Organogenesis Holdings Inc. reported $564.2M in revenue for calendar year 2025, according to its SEC filings.